Johnb Hernandez News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Published: May 13, 2021 By Alex Keown Akouos, Inc. – Kathy Reape was named chief development officer of Boston-based Akouos. Reape most recently served as chief medical officer at Spark Therapeutics where she oversaw clinical development, pharmacovigilance, and medical affairs activities. Reape was a key member of the team responsible for the development and commercialization of Luxturna, the first FDA-approved in vivo gene therapy approved for an inherited retinal disease caused by mutations in both copies of the RPE65 gene. Prior to Spark, Reape was senior vice president of clinic...

(0) Regulatory News: CARMAT (FR0010907956, ALCAR), the designer and developer of the world's most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic alternative to people suffering from end-stage biventricular heart failure, informs its shareholders that the annual general meeting (AGM) of May 12, 2021 was able to deliberate, quorum having been reached. Given the ongoing restrictions associated with the COVID-19 context, CARMAT's AGM was held behind closed doors and streamed online. This AGM approved all the resolutions tabled, with the excepti...

CARMAT :'s Board of Directors is reorganising its governance and proposes the appointment of three new directors to support the new strategic phase of industrialization and commercialization 05/07/2021 | 01:01am EDT Send by mail : Message : Required fields The Board of Directors warmly thanks Dr. Philippe Pouletty, Managing Director of Truffle Capital, for his exceptional contribution to the development of the CARMAT project, and proposes the appointment of three new directors, Florent Battistella, David Coti and John B. Hernandez. Regulatory News: CARMAT (FR0010907956, ALCAR), the designer ...